A New York-based biotech company is turning heads on Tuesday after it announced it signed a material transfer agreement to supply SLS-002 for the Department of Defense’s...

To read the full story on AllPennyStocks.com, click here.

Seelos Therapeutics (NASDAQ:SEEL)
過去 株価チャート
から 12 2024 まで 1 2025 Seelos Therapeuticsのチャートをもっと見るにはこちらをクリック
Seelos Therapeutics (NASDAQ:SEEL)
過去 株価チャート
から 1 2024 まで 1 2025 Seelos Therapeuticsのチャートをもっと見るにはこちらをクリック